Disease/Infection News

RSS

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Researchers review critically evaluated the transmission dynamics of SARS-CoV-2 across various ages in metropolitan France.

1 Dec 2021

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.

1 Dec 2021

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

New research suggests that a fourth dose of the mRNA-1273 vaccine in kidney transplant recipients improves Delta variant serum neutralization.

1 Dec 2021

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

New analysis highlights the global prevalence of HIV among transgender people

A new analysis highlights the prevalence of HIV among transgender individuals worldwide, and shows the need for continued prevention efforts for this population.

1 Dec 2021

First U.S. case of omicron variant detected in California

The California and San Francisco Departments of Public Health have confirmed that a recent case of COVID-19 among an individual in California was caused by the Omicron variant (B.1.1.529).

1 Dec 2021

World AIDS Day: New Vital Signs report highlights persistent disparities in HIV prevention and care

Despite overall progress in reducing new infections among gay and bisexual men, the HIV epidemic continued and was more severe among Black or African American (hereafter referred to as Black) and Hispanic/Latino gay and bisexual men in the decade leading up to the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, which the U.S. Department of Health and Human Services launched in 2019.

1 Dec 2021

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

An agent-based simulator was used to determine the historical course of COVID-19 and to analyze the effectiveness of lockdown.

1 Dec 2021

Safety and immunogenicity of different COVID-19 booster vaccines

New study findings suggest that booster vaccination with an mRNA-based vaccine has the highest immunogenicity against the COVID-19 Delta variant.

1 Dec 2021

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

A team of researchers from UK and US institutions created a large panel of mAbs derived from memory B cells of convalescent Beta subjects to better understand the antigenic landscape of Beta.

1 Dec 2021

Plant-derived virus-like particle vaccines against SARS-CoV-2

In a review published in Biotechnology Letters, the authors discuss plant-derived VLP-based vaccines.

1 Dec 2021

Interventions for preventing COVID-19 outbreaks in military basic training

New research findings suggest that military basic training is a unique environment that necessitates the development of tailored solutions for minimizing COVID-19 outbreaks.

1 Dec 2021

Severe COVID-19 survivors have more than twice the risk of dying over the next year

Can long Covid kill? Striking findings presented in a new study published to Frontiers in Medicine show that patients who survive severe Covid-19 have more than twice the risk of dying over the following year, compared with those who experience mild or moderate disease or remain uninfected.

1 Dec 2021

People with allergic conditions may have a lower risk of COVID-19 infection, finds study

People with allergic conditions such as hay fever, rhinitis, and atopic eczema, may have a lower risk of COVID-19 infection, especially if they also have asthma, finds a large, population-based study of UK adults, published online in the respiratory journal Thorax.

1 Dec 2021

Disease/Infection News

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Study analyzes global COVID-19 vaccination rates among people living with HIV

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

New analysis highlights the global prevalence of HIV among transgender people

First U.S. case of omicron variant detected in California

World AIDS Day: New Vital Signs report highlights persistent disparities in HIV prevention and care

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

Safety and immunogenicity of different COVID-19 booster vaccines

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

Plant-derived virus-like particle vaccines against SARS-CoV-2

Interventions for preventing COVID-19 outbreaks in military basic training

Severe COVID-19 survivors have more than twice the risk of dying over the next year

People with allergic conditions may have a lower risk of COVID-19 infection, finds study

Impact of SARS-CoV-2 on oral health

Role of interferon type I-driven responses associated with disease control in COVID-19

Novel nanopore technique for annotation of SARS-CoV-2 capping sites and understanding sgRNA structure

COVID-19 vaccination status based infection likelihood in New Zealand

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News